Arabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer’s disease in vitro. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.